Author Guidelines

General guidelines

Submission of Papers

All submissions to Research in Pharmacy must be submit as a email attachment ( Word document is acceptable format, it is recommended that all tables and figures be assembled into a single file together with the main text when submitted.

The manuscript must be accompanied by a cover letter stating the title of the manuscript, names of each author, and complete mailing address(es), telephone and fax number(s) of the corresponding author, electronic mail address(es). Manuscripts should be single-spaced and all pages, including the abstract, figures, and tables, should be numbered in sequence. Manuscript pages must have margins of at least 2.5 cm on all four sides.

Editorial Policy

Only papers that report novel and significant scientific findings in pharmacy will be considered and accepted for publication. Manuscripts submitted to RIP must represent reports of original research. A manuscript will be accepted on the conditions that the presented work was not published previously, and is not under consideration for publication elsewhere.

Anyone who made a substantial contribution to the work may be included in the author list. All authors of each manuscript are responsible for the entire paper and must have agreed that the corresponding author has the authority to act on their behalf on all matters pertaining to publication of the manuscript. To avoid any possible dispute during processing, authorship changes including the order of authors’ names during revision must be agreed upon by all of the authors and brought to the editor’s attention in the cover letter submitted with the revised version.

Ethical Aspects

Manuscripts dealing with any experimental work on human or animal materials should meet the relevant regulations or requirements imposed by institutional or governmental authorities, and this should be clearly stated in the manuscript. The editor reserves the right to reject papers if ethical aspects are in doubt. Nucleotide and Amino Acid Sequences any novel nucleotide or amino acid sequences described should be deposited in a public database, such as GenBank, EMBL or DDBJ, and the accession numbers should be included in a separate paragraph in the Materials and Methods section. It is expected that the sequence data will be publicly available no later than the publication of the article.

Review Process

All manuscript is reviewed confidentially by members of the editorial board and qualified reviewers. The reviewers operate under the guidelines for reviewers and are expected to complete their reviews as soon as possible.

Notification of Acceptance

When an editor has decided that a manuscript is acceptable for publication, the corresponding author will be notified. The editorial office will check if the manuscript was prepared according to the guidelines, however the authors are primarily responsible for the format and quality of the paper.

Galley Proofs

The editorial office sends a galley proof and a agreement for publication form to the corresponding author. Galley proof should be corrected, signed by the corresponding author and send back to the editorial office within 5 days, however extensive corrections, additions, or deletions should not be made during the proof stage. Important new information or references of unpublished data or personal communications that have become available in the time between acceptance of the manuscript and receipt of the proofs may be inserted. Otherwise, changes are limited to correction of spelling errors, incorrect data, grammatical errors and updated information regarding references.

Organization and Format

General Organization The most desirable plan for the organization of a paper is as follows: (a) Abstract, in less than 250 words, (b) Introduction, in less than two typed pages, (c) Materials and Methods, (d) Results, (e) Discussion, (f) Acknowledgments, (g) References. In some cases the presentation might be more effective if you combined some sections, e.g. Results and Discussion. This is particularly true in short papers. The Journal imposes no lower limit on the size of regular papers.

The title should be informative and as short as is consistent with clarity.

List full names of all authors. A footnote to an author, indicating a change of address, should be given on the title page using one of the following superscript: 1, 2, 3. The asterisk symbol * should be reserved for the author to whom correspondence should be addressed.

List the institutions in which the work was carried out. Identify the affiliations of all authors and their institutions, departments, or organizations by use of superscript lower case alphabets.

The Abstract should not exceed 250 words, and should concisely summarize the basic content of the paper. Experimental details should not be presented in the abstract. Avoid specialized terms, abbreviations, diagrams, and references.

Introduction states the purpose of the investigation and its relation to other works in the same field, but should not present an extensive review of the literature.

The descriptions in Materials and Methods should be brief, but sufficiently detailed to permit repetition of the work by a qualified operator. Refer to published procedures by citing both the original description and pertinent published modifications. Do not include extensive details unless they constitute a significant new modification.

Results should describe the results of the experiments. Present the results as concisely as possible in one of the following: text, table(s), or figure(s). Avoid presenting essentially similar data in both table and figure form. Also avoid extensive use of graphs to present data that might be more concisely presented in the text or tables. Limit photographs to those that are absolutely necessary for presenting the experimental findings. Number figures and tables according to the order of citation in the text.

Discussion should be concise and provide an interpretation of the results in relation to previously published work and to the experimental system at hand. It should not contain extensive repetition of the Results section or reiteration of the Introduction.

Acknowledge personal assistance and financial assistance in the same paragraphs.

Citations of revelant published work in the text, from Introduction to Discussion should read John (2010) or (John, 2010). When a paper cited has three or more authors, use the style Kumar et al. (2012) of (Kumar et al., 2012).

References section must be in alphabetical order by the first author. Use the following style:

Article in a periodical:
Lee S, Jeon JS, Jung KH, An G. 1999. Binary vectors for efficient transformation of rice. J. Plant Biol. 42: 310-316.

Article in a book:
Daniell, H., Camrmona-Sanchez, O., and Burns, B. 2004. Chloroplast derived antibodies, biopharmaceuticals and edible vaccines. In Molecular Farming, Eds. R. Rischer and S. Schillberg, Weinheim, Germany: Wiley-VCH Verlag, pp. 113-133.

An entire book:
Wickner, R.B., Esteban, R., and Suzuki, N. 2000. Virus Taxonomy, California: Academic Press.

References should include only articles that are published or in press. Do not list Unpublished data, submitted manuscripts, abstracts, and personal communications.

Responsibility for the accuracy of bibliographic references rests entirely with the author(s).

Tables should be numbered consecutively with Arabic numbers in order of appearance in the text. Type each table single-spaced on a separate page with short descriptive title typed directly above and with essential footnotes below. Footnotes to tables should be identified with the italic superscript lower case and placed at the bottom of the table.

Figures should be approximately the same size as you would like to appear in press. Prepare and save your figures as .gif, .jpeg more than 300 dpi resolution. Number figures consecutively with Arabic numbers. Figure legends should provide enough information for the figure to be understandable without frequent reference to the text. Define all symbols and abbreviations used in the figure that have not been defined elsewhere.


Submission of a manuscript implies: that the work described has not been published before (except in the form of an abstract or as part of a published lecture, review, or thesis); that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors, if any, as well as – tacitly or explicitly – by the responsible authorities at the institution where the work was carried out. The author warrants that his/her contribution is original and that he/she has full power to make this grant. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors. Transfer of copyright to Research in Pharmacy becomes effective if and when the article is accepted for publication. After submission of the Copyright Transfer Statement signed by the corresponding author, changes of authorship or in the order of the authors listed will not be accepted.